Immunocore’s (IMCR) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report issued on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $71.00 price objective on the stock. IMCR has been the subject of a number of other reports. HC Wainwright reiterated a “buy” rating and […]
Needham & Company LLC reaffirmed their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report issued on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $71.00 price objective on the stock. IMCR has been the subject of a number of other reports. HC Wainwright reiterated a “buy” rating and […]
